Compare
Sensus Healthcare, Inc. vs Orchestra BioMed Holdings, Inc. vs Baird Medical Investment Holdings Ltd vs DarioHealth Corp.
| Latest fiscal year | Sensus Healthcare, Inc. SRTS | Orchestra BioMed Holdings, Inc. OBIO | Baird Medical Investment Holdings Ltd BDMD | DarioHealth Corp. DRIO |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $27.48M | $33.48M | $22.54M | $22.36M |
| Revenue growth (YoY) | -34.3% | n/m | -39.2% | -17.3% |
| Gross margin | 43.2% | n/a | 83.8% | 56.6% |
| Operating margin | -37.5% | -154.7% | -113.7% | -163.9% |
| Net margin | -28.1% | -157.4% | -122.2% | -186.6% |
| Net income | -$7.72M | -$52.70M | -$27.54M | -$41.71M |
| EPS (Diluted) | -$0.47 | -$1.11 | -$0.98 | $10.12 |
| Operating cash flow | $528.0K | -$48.96M | -$1.34M | -$25.94M |
| Free cash flow | $332.0K | -$49.45M | -$1.39M | -$26.08M |
| Cash & equivalents | $22.08M | $34.69M | $178.3K | $21.80M |
| Total assets | $53.04M | $114.86M | $69.70M | $110.08M |
| Total liabilities | $4.94M | $51.48M | $38.48M | n/a |
| Shareholders' equity | $48.10M | $53.57M | $31.22M | $67.92M |
| Return on year-end equity | -16.0% | -98.4% | -88.2% | -61.4% |
| Shares outstanding | 16.46M | 57.03M | 30.75M | 6.91M |
Revenue, most recent five fiscal years
| Fiscal year | Sensus Healthcare, Inc. | Orchestra BioMed Holdings, Inc. | Baird Medical Investment Holdings Ltd | DarioHealth Corp. |
|---|---|---|---|---|
| Latest | $27.48M Ended 2025-12-31 | $33.48M Ended 2025-12-31 | $22.54M Ended 2025-12-31 | $22.36M Ended 2025-12-31 |
| 1 year earlier | $41.81M Ended 2024-12-31 | $2.64M Ended 2024-12-31 | $37.04M Ended 2024-12-31 | $27.04M Ended 2024-12-31 |
| 2 years earlier | $24.41M Ended 2023-12-31 | $2.76M Ended 2023-12-31 | $31.46M Ended 2023-12-31 | $20.35M Ended 2023-12-31 |
| 3 years earlier | $44.53M Ended 2022-12-31 | $3.53M Ended 2022-12-31 | $35.09M Ended 2022-12-31 | $27.66M Ended 2022-12-31 |
| 4 years earlier | $27.04M Ended 2021-12-31 | n/a | n/a | $20.51M Ended 2021-12-31 |